Search results
MIRA reports promising Ketamir-2 study, eyes FDA submission By Investing.com
Investing.com· 2 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a company specializing in neurologic and neuropsychiatric...
1 in 5 children and adolescents globally have 'excess weight,' new study finds. Here's what parents...
Yahoo Life Style via AOL· 1 hour agoAdditionally, longer sleep times are associated with a lower BMI, while more screen time and less...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 hour agoRICHMOND, Va., June 10, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced the dosing of the first subject with INDV-2000 in a Phase 2 double-blind, placebo controlled, randomized ...
Psychosocial skills can stop relapse in people with eating disorders, says expert
Medical Xpress· 2 hours agoHealth services should teach patients with eating disorders psychosocial skills to help more people...
Study: High-dose general anesthesia doesn't raise risk of delirium after surgery
UPI· 3 hours agoA study of more than 1,000 patients who had heart surgery at four hospitals in Canada found that the amount of anesthesia used did not affect the risk of delirium after surgery ...
Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine...
KOLR - KSFX Ozarks· 8 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders ...
Two new conditions added to medical marijuana program. See what they are.
Hartford Courant· 40 minutes agoAutism spectrum disorder and female orgasmic difficulty/disorder are the latest qualifying additions...
Alcohol use tied to mood instability in patients with bipolar disorder
Medical Xpress· 6 hours agoAlcohol use is associated with mood instability (depression and manic symptoms) in people with...
Capricor Advances in DMD Therapy With Positive Study Data - Hims & Hers Health (NYSE:HIMS), Capricor...
Benzinga· 18 minutes agoCapricor Therapeutics CAPR, a biotechnology firm focused on innovative therapies for rare diseases, has announced favorable three-year results from the ongoing HOPE-2 open-label extension (OLE ...
Bipolar disorder and intelligence: Is there a connection?
Medical News Today· 6 days agoBipolar disorder does not affect a person’s intelligence. Studies also suggest that having high...